Becaplermin biosimilar (Virchow Group)

贝卡普勒明生物类似药 (Virchow Group)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBecaplermin biosimilar (Virchow Group)

Drug Alias NameBecaplerminum (Virchow Group)贝卡普勒明生物仿制药 (Virchow Group)Recombinant human platelet-derived growth factor-BB gelBecaplermina (Virchow Group)Healace +[6]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionPlatelet-derived growth factor receptor beta agonists

TargetsPlatelet-derived growth factor receptor beta

Therapy Area/IndicationsDiabetic Foot

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesVirchow Group

China Registration ClassN/A

Develop Information

Active CompaniesVirchow Group

Inactive CompaniesN/A

Active IndicationsDiabetic Foot

Inactive IndicationsN/A

Other Information

ATC CodeA01AD08D03AX06